ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 221266 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 221266; 2) Community: the network communities that were significantly associated with the response to NSC 221266; 3) Molecule: the relationships between components within communities and NSC 221266; 4) MDR: the compounds that were significantly associated with the NSC 221266.

NSC Compound Enrichment Correlation
NSC 716915 Null 0.0133299224082802 0.2942129
NSC 726770 Cis-6-(2-dimethylamino-1-ethyl)-5,6,12,13-tetrahydro-2,3-dim ethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno-[1,2-c]iso quinoline 0.0133299224082802 0.61310002
NSC 727082 16-[3-Methoxy-4-(2-piperidin-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0133299224082802 0.15528384
NSC 745321 Null 0.0133299224082802 0.089611979
NSC 752203 Null 0.0133299224082802 -0.23881386
NSC 755427 Null 0.0133299224082802 0.45899116
NSC 759852 Vorinostat (USAN) 0.0133299224082802 0.28662088
NSC 102225 Null 0.0133299224082803 0.26013442
NSC 132277 Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) 0.0133299224082803 0.36555806
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0133299224082803 0.41230228
Total:120  Current:49    [First] [Prev] [Next] [Last]